Based on mechanistic evidence of IgE-mediated immune surveillance, we hypothesize that AR and eczema reduce lung cancer risk via enhanced antitumor immunity, with effects modulated by allergy type, gender, and geographic context. Here, IGHE is linked to allergic disease.